Literature DB >> 24942207

Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Mark P Chao1, Jison Hong, Christian Kunder, Laura Lester, Stanley L Schrier, Ravindra Majeti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24942207      PMCID： PMC5435183          DOI： 10.1002/ajh.23791

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  15 in total

1.  IgM autoagglutinins in warm autoimmune hemolytic anemia: a poor prognostic feature.

Authors:  E L McCann; R S Shirey; T S Kickler; P M Ness
Journal:  Acta Haematol       Date:  1992       Impact factor: 2.195

2.  Severe autoimmune hemolytic anemia associated with IgM warm auto-antibodies in primary Sjögren's syndrome.

Authors:  Koichiro Shinoda; Hirofumi Taki; Hiroyuki Hounoki; Reina Ogawa; Eiji Sugiyama; Kazuyuki Tobe
Journal:  Int J Rheum Dis       Date:  2010-02-01       Impact factor: 2.454

3.  Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib.

Authors:  Kenneth R Carson; Lee G Beckwith; Jayesh Mehta
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

4.  Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease.

Authors:  Alexander Röth; Andreas Hüttmann; Russell P Rother; Ulrich Dührsen; Thomas Philipp
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

5.  Fatal autoimmune hemolytic anemia in a child due to warm-reactive immunoglobulin M antibody.

Authors:  A M Friedmann; K E King; R S Shirey; L M Resar; J F Casella
Journal:  J Pediatr Hematol Oncol       Date:  1998 Sep-Oct       Impact factor: 1.289

6.  Successful response to alpha-interferon 2b in a refractory IgM autoagglutinin-mediated hemolytic anemia.

Authors:  T Fest; B de Wazières; B Lamy; M Maskani; D Vuitton; J L Dupond
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

7.  Evaluation of dithiothreitol (DTT) for inactivation of IgM antibodies.

Authors:  T Okuno; N Kondelis
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

8.  Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies.

Authors:  Patricia A Arndt; Regina M Leger; George Garratty
Journal:  Transfusion       Date:  2008-10-28       Impact factor: 3.157

Review 9.  World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.

Authors:  Jason Gotlib
Journal:  Am J Hematol       Date:  2014-03       Impact factor: 10.047

10.  Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency.

Authors:  Mary Wakim; Ami Shah; Patricia A Arndt; George Garratty; Kenneth Weinberg; Thomas Hofstra; Joseph Church
Journal:  Am J Hematol       Date:  2004-06       Impact factor: 10.047
View more
  5 in total

1.  Severe refractory idiopathic warm autoimmune haemolytic anaemia responsive to complement inhibition with eculizumab.

Authors:  Lucy Neave; Andrew J Wilson; Maxine Lissack; Marie Scully
Journal:  BMJ Case Rep       Date:  2018-12-13

Review 2.  The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia.

Authors:  Mirela Raos; Marija Lukic; Drazen Pulanic; Marijo Vodanovic; Branka Golubic Cepulic
Journal:  Blood Transfus       Date:  2021-10-15       Impact factor: 5.752

Review 3.  Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Authors:  Francesco Muratore; Giulia Pazzola; Alessandra Soriano; Nicolò Pipitone; Stefania Croci; Martina Bonacini; Luigi Boiardi; Carlo Salvarani
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

4.  Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab.

Authors:  Emma Marguerite Jackson; Simon Harper; Gwilym J Webb; Will Thomas
Journal:  BMJ Case Rep       Date:  2022-08-31

5.  Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy.

Authors:  Kim Ma; Stephen Caplan
Journal:  Case Rep Hematol       Date:  2016-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.